Products & Services
Markets
Contact Us
Become a Partner
Blog
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Blog
Reach out to us on
0120-4918900
Or
Get a call back
Click here
Markets
Company Info
Equity
IPO
Company Info
Derivatives
News
Announcements
Mutual Fund
Insurance
Share Price
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
BOARD MEETING
You can view Board Meeting of the company.
Aarti Drugs Ltd.
GO
Apr 25
BSE
350.70
( -15.05 -4.11%)
Volume
7116
Prev. Close
365.75
Open Price
365.30
Today's Low / High
347.30
365.30
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
312.50
634.90
Apr 25
NSE
350.80
( -15.05 -4.11%)
Volume
151985
Prev. Close
365.85
Open Price
368.60
Today's Low / High
347.10
368.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
312.00
635.00
ISIN No
INE767A01016
Market Cap. (
in Cr. )
3201.75
P/BV
2.51
Book Value (
)
139.96
BSE Code
524348
52 Week High/Low (
)
635/312
FV/ML
10/1
P/E(X)
18.68
NSE Code
AARTIDRUGSEQ
Book Closure
04/02/2025
EPS (
)
18.78
Div Yield (%)
0.29
Date
Purpose
29/01/2025
Quarterly Results & Interim Dividend
24/10/2024
Quarterly Results
26/08/2024
Buy Back of Shares
26/07/2024
Quarterly Results
03/05/2024
Audited Results
24/01/2024
Quarterly Results & Interim Dividend
19/10/2023
Quarterly Results
21/07/2023
Quarterly Results & Buy Back
29/04/2023
Audited Results
27/01/2023
Quarterly Results & Interim Dividend